164 results
Page 5 of 9
6-K
EX-99.2
nsgyog mf
27 Nov 19
Condensed Consolidated Interim Financial Statements
5:09pm
6-K
EX-99.1
g97os ord
26 Nov 19
RepliCel Provides 2019 Year-End Update
12:41pm
6-K
EX-99.5
94r7 ydjjwk
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
4wg6fspsa2mnukq4j
24 Sep 19
Current report (foreign)
1:49pm
6-K
EX-99.2
gcacbh8ek29r8e
20 Sep 19
51-102F3 Material Change Report
1:31pm
6-K
EX-99.2
vac6z s9899kteea
11 Sep 19
51-102F3 Material Change Report
12:13pm
6-K
EX-99.3
ak6t09tm
11 Sep 19
51-102F3 Material Change Report
12:13pm
6-K
EX-99.1
9lw4 fu1tg5
10 Sep 19
RepliCel's Partner, YOFOTO (China) Health, Unveils its Inaugural Cell Therapy Manufacturing Facility in China
11:22am
6-K
EX-99.1
8ko1ylyz0dhxjuu c1oy
29 Aug 19
RepliCel Life Sciences Retains Dermatology Sales and Marketing Executive to Guide the Global Commercial Strategy for its Automated Dermal Injector
11:47am
6-K
EX-99.2
6bjlbf 0m35k
23 Aug 19
Condensed Consolidated Interim Financial Statements
3:47pm
6-K
EX-99.2
6wk2yowdvtklvd9xns
30 May 19
Condensed Consolidated Interim Financial Statements
4:20pm
6-K
EX-99.1
5mnls1mt8tqniihzsd
16 Apr 19
RepliCel Secures Several New Patents for its Regenerative Medicine Technologies
10:59am
6-K
EX-99.1
v0m71rgwdk1n
26 Mar 19
Current report (foreign)
1:45pm
6-K
EX-99.1
3xk2sth0 8ljkqm
19 Mar 19
RepliCel Reignites its First-in-Japan Strategy
12:11pm
6-K
EX-99.1
rqqr93
6 Mar 19
51-102F3 Material Change Report
4:53pm
6-K
EX-99.1
ja8524oc tlocua9
5 Mar 19
RepliCel CEO Provides 2019 Shareholder Update
10:41am
6-K
EX-99.1
7voof5vem rqu8
23 Jan 19
51-102F3 Material Change Report
12:44pm
6-K
EX-99.2
3njwncwlkac7 6wk
26 Nov 18
Current report (foreign)
4:20pm
6-K
EX-99.1
nlh 4id8y50
6 Nov 18
RepliCel Life Sciences Appoints Head of Clinical and Regulatory Affairs
11:03am